Epoetin alfa reduces anemia in breast cancer patients with no negative impact on survival
In patients with high-risk breast cancer, addition of the erythropoiesis-stimulating agent (ESA) epoetin alfa to the chemotherapy regimen may help avoid the decrease in hemoglobin levels and resulting anemia often seen in ...
Jul 17, 2013
0
0